These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 9302387)

  • 1. Elevated leptin concentrations in growth hormone-deficient hypopituitary adults.
    al-Shoumer KA; Anyaoku V; Richmond W; Johnston DG
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):153-9. PubMed ID: 9302387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipid and leptin concentrations in hypopituitary patients with growth hormone deficiency.
    Ozbey N; Algun E; Turgut AS; Orhan Y; Sencer E; Molvalilar S
    Int J Obes Relat Metab Disord; 2000 May; 24(5):619-26. PubMed ID: 10849585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults.
    Beshyah SA; Freemantle C; Thomas E; Rutherford O; Page B; Murphy M; Johnston DG
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):179-89. PubMed ID: 7704962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
    Florakis D; Hung V; Kaltsas G; Coyte D; Jenkins PJ; Chew SL; Grossman AB; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):453-9. PubMed ID: 11012570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of leptin, incretins and body composition in obese and lean patients with hypopituitarism and healthy individuals.
    Mersebach H; Svendsen OL; Holst JJ; Astrup A; Feldt-Rasmussen U
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):65-71. PubMed ID: 12519414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities.
    Abdu TA; Neary R; Elhadd TA; Akber M; Clayton RN
    Clin Endocrinol (Oxf); 2001 Aug; 55(2):209-16. PubMed ID: 11531927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.
    al-Shoumer KA; Cox KH; Hughes CL; Richmond W; Johnston DG
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2653-9. PubMed ID: 9253349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database.
    Monson JP; Abs R; Bengtsson BA; Bennmarker H; Feldt-Rasmussen U; Hernberg-Stâhl E; Thorén M; Westberg B; Wilton P; Wüster C
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):281-9. PubMed ID: 10971444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intima-media thickness in cardiovascularly asymptomatic hypopituitary adults with growth hormone deficiency: relation to body mass index, gender, and other cardiovascular risk factors.
    Leonsson M; Hulthe J; Oscarsson J; Johannsson G; Wendelhag I; Wikstrand J; Bengtsson BA
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):751-9. PubMed ID: 12460325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors.
    Liuzzi A; Savia G; Tagliaferri M; Lucantoni R; Berselli ME; Petroni ML; De Medici C; Viberti GC
    Int J Obes Relat Metab Disord; 1999 Oct; 23(10):1066-73. PubMed ID: 10557027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults.
    Giavoli C; Cappiello V; Corbetta S; Ronchi CL; Morpurgo PS; Ferrante E; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):81-7. PubMed ID: 15212648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory cardiovascular risk markers in women with hypopituitarism.
    Sesmilo G; Miller KK; Hayden D; Klibanski A
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5774-81. PubMed ID: 11739438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.
    Abs R; Feldt-Rasmussen U; Mattsson AF; Monson JP; Bengtsson BA; Góth MI; Wilton P; Koltowska-Häggström M
    Eur J Endocrinol; 2006 Jul; 155(1):79-90. PubMed ID: 16793953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults.
    al-Shoumer KA; Gray R; Anyaoku V; Hughes C; Beshyah S; Richmond W; Johnston DG
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):795-802. PubMed ID: 9713570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum GHBP levels in obese pubertal children and adolescents: relationship to body composition, leptin and indicators of metabolic disturbances.
    Kratzsch J; Dehmel B; Pulzer F; Keller E; Englaro P; Blum WF; Wabitsch M
    Int J Obes Relat Metab Disord; 1997 Dec; 21(12):1130-6. PubMed ID: 9426380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction in hypopituitary adults with growth hormone deficiency.
    Evans LM; Davies JS; Goodfellow J; Rees JA; Scanlon MF
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):457-64. PubMed ID: 10468904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum adipokines and low density lipoprotein subfraction profile in hypopituitary patients with growth hormone deficiency.
    Salman S; Uzum AK; Telci A; Alagol F; Ozbey NC
    Pituitary; 2012 Sep; 15(3):386-92. PubMed ID: 21833617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) status is an independent determinant of serum levels of cholesterol and triglycerides in healthy adults.
    Vahl N; Klausen I; Christiansen JS; Jørgensen JO
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):309-16. PubMed ID: 10469010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin concentrations do not correlate with fat mass nor with metabolic risk factors in morbidly obese females.
    García-Lorda P; Bulló M; Vilà R; del Mar Grasa M; Alemany M; Salas-Salvadó J
    Diabetes Nutr Metab; 2001 Dec; 14(6):329-36. PubMed ID: 11853365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.